Part 1: Evidence-based facility design using Transforming Care at the Bedside principles.

J Nurs Adm

Author Affiliations: Former Director (Ms Devine) and Director (Ms Zwink), Medical-Surgical Nursing Services; Clinical Nurse Specialist (Ms Wenger), Professional Resources; Director (Dr Krugman), Nursing Innovation & Outcomes; Nurse Manager (Ms Shiskowsky), Pulmonary Unit; Nurse Manager (Ms Hagman), Rehabilitation and ACES Medicine Units; Nurse Manager (Ms Limon), Neuroscience; Vice President and Chief Nursing Officer (Dr Sanders); and Facility Nurse Project Manager (Ms Reeves), University of Colorado Hospital, Aurora.

Published: February 2015

An academic hospital used Transforming Care at the Bedside (TCAB) principles as the framework for generating evidence-based recommendations for the design of an expansion of the current hospital. The interdisciplinary team used the table of evidence-based data to advocate for a patient- and family-centered, safe, and positive work environment. A nurse project manager acted as liaison between the TCAB design team, architects, and facilities and design consultants. Part 2 of this series describes project evaluation outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1097/NNA.0000000000000161DOI Listing

Publication Analysis

Top Keywords

transforming care
8
care bedside
8
evidence-based facility
4
design
4
facility design
4
design transforming
4
bedside principles
4
principles academic
4
academic hospital
4
hospital transforming
4

Similar Publications

Artificial Intelligence (AI) is rapidly transforming healthcare, particularly in orthopedics, by enhancing diagnostic accuracy, surgical planning, and personalized treatment. This review explores current applications of AI in orthopedics, focusing on its contributions to diagnostics and surgical procedures. Key methodologies such as artificial neural networks (ANNs), convolutional neural networks (CNNs), support vector machines (SVMs), and ensemble learning have significantly improved diagnostic precision and patient care.

View Article and Find Full Text PDF

Background: Circular (circ)RNAs have emerged as crucial contributors to cancer progression. Nonetheless, the expression regulation, biological functions, and underlying mechanisms of circRNAs in mediating hepatocellular carcinoma (HCC) progression remain insufficiently elucidated.

Methods: We identified circUCK2(2,3) through circRNA sequencing, RT-PCR, and Sanger sequencing.

View Article and Find Full Text PDF

Transforming RN-Baccalaureate Education Using Insights From a National Faculty Needs Assessment.

Nurse Educ

January 2025

Author Affiliations: Arizona State University Edson College of Nursing and Health Innovation, Phoenix, Arizona (Dr Heywood); Wichita State University School of Nursing, Wichita, Kansas (Dr Williams); Southern New Hampshire University Nursing and Health Professions Department, Manchester, New Hampshire (Dr Blackwell); Bemidji State University Department of Nursing, Bemidji, Minnesota (Dr Hommes); University of Mississippi Medical Center School of Nursing, Jackson, Mississippi (Professor Franklin); and Boise State University School of Nursing, Boise, Idaho (Dr Nichols).

Background: The recent American Association of Colleges of Nursing (AACN) Essentials revision emphasizes direct clinical experiences across 4 spheres of care in RN-Baccalaureate (RN-B) education, creating challenges for online, asynchronous programs. Differentiating between prelicensure and postlicensure education complicates the integration of these requirements. Understanding RN-B faculty needs is critical for curricular transformation.

View Article and Find Full Text PDF

Discovery and Development of CFTR Modulators for the Treatment of Cystic Fibrosis.

J Med Chem

January 2025

AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States.

Cystic fibrosis (CF) is a genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which regulates ion and fluid transport across epithelial cells. Mutations lead to complications, with life-limiting lung disease being the most severe manifestation. Traditional treatments focused on managing symptoms, but advances in understanding CF's molecular basis led to small-molecule CFTR modulators.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!